Last reviewed · How we verify
Danning Tablet
Danning Tablet is a traditional Chinese medicine formulation that supports hepatic function and biliary health through multi-component herbal synergy.
Danning Tablet is a traditional Chinese medicine formulation that supports hepatic function and biliary health through multi-component herbal synergy. Used for Hepatobiliary dysfunction, Post-operative hepatobiliary recovery, Chronic liver conditions.
At a glance
| Generic name | Danning Tablet |
|---|---|
| Also known as | Biliflow (NPN 80073325, manufactured by Shanghai Hutchison Pharmaceuticals Limited) |
| Sponsor | Eastern Hepatobiliary Surgery Hospital |
| Drug class | Traditional Chinese Medicine (TCM) herbal formulation |
| Modality | Small molecule |
| Therapeutic area | Hepatology / Gastroenterology |
| Phase | FDA-approved |
Mechanism of action
Danning Tablet combines multiple herbal ingredients traditionally used in Chinese medicine to promote liver and gallbladder function. The formulation is designed to improve bile flow, reduce hepatic inflammation, and support overall hepatobiliary system health. It is commonly used in clinical practice at hepatobiliary surgery centers for post-operative recovery and chronic liver-related conditions.
Approved indications
- Hepatobiliary dysfunction
- Post-operative hepatobiliary recovery
- Chronic liver conditions
Common side effects
- Gastrointestinal upset
- Mild allergic reactions
Key clinical trials
- A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms
- A Study of Danning Tablet in Patients With Polypoid Lesions of Gallbladder (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Danning Tablet CI brief — competitive landscape report
- Danning Tablet updates RSS · CI watch RSS
- Eastern Hepatobiliary Surgery Hospital portfolio CI